Archive | Conferences

Checkpoint Inhibition and Cardiotoxicity: Cause for Concern?

Source: Medscape Pharmacist, January 2019 An extensive analysis of a World Health Organization (WHO) global database has identified myocarditis, pericardial diseases, cardiac arrhythmias, and vasculitis as significant immune-related cardiac toxicities associated with the use of immune checkpoint inhibitors (ICIs) in routine clinical practice. These cardiotoxicities were seen more often in men than women. Pericardial diseases were more common […]

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

EADV report highlights the future of checkpoint inhibitors in advanced melanoma

Immunological response to cancer comprises a series of complex steps …

Read the full story

Posted in Melanoma News, Conferences

Treating moles and melanoma during pregnancy

The lack of any hard and fast guidelines for best clinical practices means that the management of moles and melanoma during pregnancy is a challenge…

Read the full story

Posted in Melanoma News, Conferences

ASCO 2018 Highlights: Melanoma Studies

Cancer Network: Are there one or two key presentations of clinical trial data at the meeting that you feel could potentially be practice-changing?

Read the full story

Posted in Melanoma News, Conferences